Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study
克唑替尼治疗ALK阳性肿瘤(不包括非小细胞肺癌)的长期疗效:一项1b期开放标签研究
期刊:American Journal of Hematology
影响因子:9.9
doi:10.1002/ajh.25043
Gambacorti-Passerini, Carlo; Orlov, Sergey; Zhang, Li; Braiteh, Fadi; Huang, Huiqiang; Esaki, Taito; Horibe, Keizo; Ahn, Jin-Seok; Beck, Joseph T; Edenfield, William Jeffrey; Shi, Yuankai; Taylor, Matthew; Tamura, Kenji; Van Tine, Brian A; Wu, Shang-Ju; Paolini, Jolanda; Selaru, Paulina; Kim, Tae Min